CAS 15384-34-6

(3R,5R)-3,4-dihydroxy-5-(hydroxyméthyl)tetrahydrofurane-2-one

Formule : C₅H₈O₅

InChI : InChI=1/C5H8O5/c6-1-2-3(7)4(8)5(9)10-2/h2-4,6-8H,1H2/t2-,3?,4-/m1/s1

SMILES : C([C@@H]1C([C@H](C(=O)O1)O)O)O

(3S, 4R, 5R)-3, 4-Dihydroxy-5-(hydroxymethyl)dihydrofuran-2(3H)-one

CAS : 15384-34-6

(3S, 4R, 5R)-3, 4-Dihydroxy-5-(hydroxymethyl)dihydrofuran-2(3H)-one

Formule : C₅H₈O₅

Degré de pureté : ≥95%

Masse moléculaire : 148.11

Ref: 54-OR1112634

D-Lyxono-1,4-lactone

CAS : 15384-34-6

D-Lyxono-1,4-lactone is a biochemical reagent that can be used as a biomaterial for life science related research and as a sulfonylation reagent for organic synthesis and drug discovery.

Formule : C₅H₈O₅

Masse moléculaire : 148.11

Ref: TM-TSW-00226

D-Lyxono-1,4-lactone

CAS : 15384-34-6

Masse moléculaire : 148.11

Ref: 7W-GC1501

D-Lyxono-1,4-lactone

CAS : 15384-34-6

D-Lyxono-1,4-lactone is a 4-deoxy-l-fucose derivative that is a potent inhibitor of bacterial growth. It is a highly effective antibiotic with a broad spectrum of activity against Gram-positive and Gram-negative bacteria. D-Lyxono-1,4-lactone has been shown to be active against multivorans, including Escherichia coli and Salmonella enterica serovar Typhimurium. This compound was found to be more active than antibiotics such as penicillin and streptomycin. The structure of D-Lyxono-1,4-lactone includes two hydroxamic acid groups that are connected by an acetal linkage to form the benzylidene acetal moiety. The optical enantiomers of this molecule have been characterized using high resolution NMR spectroscopy and magnetic resonance spectroscopy techniques.BR> Dosis: 250

Formule : C₅H₈O₅

Degré de pureté : Min. 95.0 Area-%

Masse moléculaire : 148.11 g/mol

Ref: 3D-W-201380

D-Lyxono-1,4-lactone

CAS : 15384-34-6

D-Lyxono-1,4-lactone is an inhibitor of the enzyme fucosidase. It competitively inhibits the enzyme, but does not inhibit other hydroxamic acids such as enantiomers of D-lyxono-1,4-lactone. D-Lyxono-1,4-lactone has been used to treat HIV and AIDS because it prevents viral replication by blocking the synthesis of glycoproteins in the virus's envelope. It also has inhibitory effects on tumor cells that are not dependent on fucosidase activity. Magnetic resonance spectroscopy (NMR) studies have shown that d-lyxono-1,4-lactone binds to human liver cells and blocks the binding site for cytotoxic molecules in these cells. The molecular modelling study has demonstrated that d-lyxono 1,4 lactone binds to a specific site on human HLA class II molecule and reduces its

Formule : C₅H₈O₅

Degré de pureté : (%) Min. 97%

Couleur et forme : Powder

Masse moléculaire : 148.11 g/mol

Ref: 3D-ML05267

(3S,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)dihydrofuran-2(3H)-one

CAS : 15384-34-6

Formule : C₅H₈O₅

Degré de pureté : 95%

Masse moléculaire : 148.114

Ref: 10-F053801

D-Lyxono-1,4-lactone

Produit contrôlé

CAS : 15384-34-6

Applications D-Lyxono-1,4-lactone is used for synthesis of 1,4-dideoxy-1,4-imino-L-arabinitol, a glucosidase inhibitor with in vitro antiviral activity.
References Mitrakou, A., et al.: Diab. Med., 15, 657 (1998), Scott, L., et al.: Drugs, 59, 521 (2000), Vasella, A., et al.: Curr. Opin. Chem. Biol., 6, 619 (2002), Kato, A., et al.: J. Med. Chem., 48, 2036 (2005),

Formule : C₅H₈O₅

Couleur et forme : Neat

Masse moléculaire : 148.11

Ref: TR-L490000

D-Lyxonic acid, g-lactone

CAS : 15384-34-6

Formule : C₅H₈O₅

Degré de pureté : 95%

Couleur et forme : Solid

Masse moléculaire : 148.1140

Ref: IN-DA00HY6A